Physician profile
Karlye Kerr
NPI 1710661772
$1,786.33
in general payments reported to CMS, 2019-2025
15 companies · $488 in 2025
The $488 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $228 · 2024: $1,071 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,773 · Education: $13.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,772.81 |
| Education | $13.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $364.71 | 2023-2025 | Caplyta |
| Axsome Therapeutics, INC. | $174.89 | 2023-2025 | Auvelity |
| Corium, LLC | $168.77 | 2023-2024 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $161.21 | 2023-2025 | Rexulti |
| Neurocrine Biosciences, INC. | $150.16 | 2024-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $148.03 | 2024 | Austedo Xr |
| Lundbeck LLC | $139.64 | 2024-2025 | Rexulti |
| Alkermes, INC. | $106.72 | 2024-2025 | Lybalvi, Aristada |
| Ironshore Pharmaceuticals INC. | $105.33 | 2023-2024 | Jornay Pm |
| Janssen Pharmaceuticals, INC | $74.15 | 2025 | Spravato, Invega Sustenna |
| Vanda Pharmaceuticals INC. | $67.22 | 2024-2025 | Fanapt |
| Abbvie INC. | $51.45 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.86 | 2024-2025 | Trintellix |
| Neos Therapeutics, LP | $28.52 | 2024 | Adzenys Xr-Odt |
| Collegium Pharmaceutical, INC. | $16.67 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karlye Kerr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.